Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor
- PMID: 9871573
- DOI: 10.1016/s0960-894x(98)00079-1
Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor
Abstract
Systematic variation of the so-called P-pocket moiety of benzamidrazone-based selective thrombin inhibitors led to the discovery of LB30057. It is potent (Ki = 0.38 nM for human thrombin), selective (Ki = 3290 nM for bovine trypsin), and orally bioavailable (58% oral bioavailability in dogs). LB30057 was efficacious in thrombosis animal models.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information